Retina Specialists of Southern Arizona
(520) 881-1400
Office Hours
Mon - Fri 8:00am - 4:30pm

Published Articles & Research

John Christoforidis, M.D., Ophthalmologist

  • Christoforidis, JB; DeAngelo, Daniel, J; D'Amico, Donald J.(2003). Resolution of leukemic retinopathy following treatment with imatinib mesylate for chronic myelogenous leukemia. . American journal of ophthalmology. Vol. 135, no. 3. : 398-400.
  • Christoforidis, JB; Caruso, Paul, A; Curtin, Hugh, D; Fiore, Tito; D'Amico, Donald J. (2003). CT characteristics of intraocular perfluoro-N-octane. . AJNR. American Journal of Neuroradiology. Vol. 24, no. 9. (September): 1769-1771.
  • Tsilimbaris, Miltiadis; Lit, Eugene, S; Christoforidis, JB; D'Amico, Donald J. (2004). In vivo rabbit eyecup preparation for use in retinal research. Investigative Ophthalmology & Visual Science. Vol. 45, no. 3. (March): 906-909.
  • John B. Christoforidis, MD; Donald J. D'Amico. (2004). Surgical and other treatments of diabetic macular edema: an update. International Ophthalmology Clinics. Vol. 44, no. 1. (January): 139-160.
  • Christoforidis JB, Adamis AP, D'Amico DJ. (2005). NSAID Fails to Retard Diabetic Macular Edema. Review of Ophthalmology Retina Online. Vol. 1, no. 2. Edited by Philip Rosenfeld, M.D., Ph.D.
  • Yu, Seung-Young; Viola, Francesco; Christoforidis, JB; D'Amico, Donald J. (2005). Dystrophic calcification of the fibrous capsule around a hydrogel explant 13 years after scleral buckling surgery: capsular calcification of a hydrogel explant. Retina (Philadelphia, Pa.). Vol. 25, no. 8. (December): 1104-1107.
  • Christoforidis, JB; Warden, Scott, M; Demattia, Massimo; D'Amico, Donald J. (2006). In vivo redirection of retinal blood flow into borosilicate micro-cannulas in rabbits. Graefe's archive for clinical and experimental ophthalmology. Vol. 244, no. 8. : 1022-1025.
  • Warden, Scott, M; Pachydaki, Sophia, I; Christoforidis, JB; D'Amico, Donald, J; Loewenstein, John I. (2006). Choroidal neovascularization after epiretinal membrane removal. Archives of ophthalmology. Vol. 124, no. 11. (November): 1652-1654.
  • Christoforidis, JB.; Warden, Scott M.; Farrell, Gault M.; Baker, Meghan; Mukai, Shizuo. (2007). Histology of Retina Overlying Bacterial Subretinal Abscess and Implications for Treatment. Retinal Cases and Brief Reports. Vol. 1, no. 4. (April): 257-260.
  • Davis MD, Bressler SB, Aiello LP, Bressler NM, Browning DJ, Flaxel CJ, Fong DS, Foster WJ, Glassman AR, Hartnett ME, Kollman C, Li HK, Qin H, Scott IU;Davidorf FH, Christoforidis JB et al. (2008). Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Investigative Ophthalmology Visual Science. Vol. 49, no. 5. (May): 1745-1752.
  • Diabetic Retinopathy Clinical Research Network. (2008). Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology. Vol. 8, no. 115. (August): 1366-1371.
  • Richdale K, Wassenaar P, Teal Bluestein K, Abduljalil A, Christoforidis JB, Lanz T, Knopp MV, Schmalbrock P. (2009). 7 Tesla MR imaging of the human eye in vivo. Journal of Magnetic Resonance Imaging. Vol. 5, no. 30. (November 30): 924-932.
  • Christoforidis JB, Ricketts R, Loizos T and Chang S.(2011). Optical coherence tomography findings of quinine poisoning. Clinical Ophthalmology. Vol. 5. (January): 75-80.
  • Christoforidis JB, Tecce N, Dell'omo R, Mastropasqua R, Verolino M, Costagliola C.(2011). Age Related Macular Degeneration and Visual Disability. Current Drug Targets. Vol. 12. (February): 221-233.
  • Christoforidis JB.(2011). Volume of visual field assessed with kinetic perimetry and its application to static perimetry. Clinical Ophthalmology. Vol. 5. (April): 535-541.
  • CATT Research Group.(2011). Ranibizumab and bevacizumab for neovascular age-related macular degeneration. New England Journal of Medicine. Vol. 364. (April): 1897-1908.
  • JB Christoforidis, Michelle M. Carlton, Michael V. Knopp and George H. Hinkle.(2011). PET/CT imaging of I-124 radiolabeled bevacizumab and ranibizumab after intravitreal injection in a rabbit model. Investigative Ophthalmolgy & Visual Science. Vol. 52. (July): 5899-5903
  • Chang SC, Vaccarella L, Olatunji S, Cebulla C, Christoforidis JB.(2011). Diagnostic challenges to retinitis pigmentosa: genotypic multiplicity and phenotypic variability. Current Genomics. Vol. 12. (June): 267-275.
  • Gangaputra S, Almukhtar T, Glassman AR, Aiello LP, Bressler N, Bressler SB, Danis RP, Davis MD; Diabetic Retinopathy Clinical Research Network.(2011). Comparison of film and digital fundus photographs in eyes of individuals with diabetes mellitus. Invest Ophthalmol Vis Sci. Vol. 9, no. 52. (August 11): 6168-6173.
  • Christoforidis J, Zhang X.(2011). Learning effect of dark adaptation among normal subjects. Graefe's Archives for Clinical and Experimental Ophthalmology. Vol. 9, no. 249. (September): 1345-1352.
  • Christoforidis J, Ricketts R, Bean S, Pratt C, Pierce J, Wells W, Zhang X, La Perle K.(2012). The effect of intravitreal anti-VEGF agents on cutaneous wound healing in a rabbit model. Clinical Ophthalmology. Vol. 6:61-69.
  • Welling J; Tarabishy, A; Christoforidis JB.(2012). Cytomegalovirus retinitis after central retinal vein occlusion in a patient on systemic immunosuppression: Does veno-occlusive disease predispose to cytomegalovirus retinitis in patients already at risk?. Clinical Ophthalmology. Vol. 6: 601-603.
  • Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group.(2012). Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: Two-year results. Ophthalmology. 119:1388-1398.
  • Christoforidis, JB; Terrell W; Davidorf FH.(2012). The Histopathology of Optic Nerve Pit. Clinical Ophthalmology. Vol 6 (April): 1169-1174.
  • Christoforidis, JB; Chang S; Jiang A; Wang J; Cebulla C.(2012). Intravitreal devices in the treatment of vitreous inflammation. Mediators of Inflammation Nov 2012 DOI:10.1155/2012/126463
  • Christoforidis, JB; Williams MM; Kothandaraman S; Kumar K; Epitropoulos F; Knopp MV.(2012). Anatomic and pharmacokinetic properties of intravitreal I-124-aflibercept in a rabbit model using PET/CT. Current Eye Research 37: 1171-4
  • Christoforidis, JB; Chang S; Jiang A; Wang J; Cebulla C.(2012). Systemic treatment of vitreous inflammation. Mediators of Inflammation DOI: 10.1155/2012/936721
  • Romano, MR; Christoforidis, JB; Abu El-Asrar, AM.(2013). Intravitreal Inflammation: From Benchside to Bedside. Mediators of Inflammation DOI: 10.1155/2013/758035 (IF: 3.26)
  • Ying GS, Huang J, Maguire MG, Jaffe GJ, Grunwald JE, Toth C, Daniel E, Klein M, Pieramici D, Wells J, Martin DF; Comparison of Age-related Macular Degeneration Treatments Trials Research Group.(2013). Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. Ophthalmology. Jan;120(1):122-9.
  • Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Callanan DG, Kim IK, Klein ML, Maguire MG, Martin DF;(2013). Comparison of AMD Treatments Trials Research Group. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Ophthalmology. Mar;120(3):593-9
  • Christoforidis, JB; Wassenaar PA; Christoforidis GA; Ho VY; Knopp MV; Schmalbrock, PM.(2013). Retrobulbar Vasculature using 7-Tesla Magnetic Resonance Imaging with Dedicated Eye Surface Coil. Graefe's Archives for Clinical and Experimental Ophthalmology Vol. 251 (January): 271-7
  • Christoforidis, JB; Wang, J; Jiang, A; Willard, J; Pratt, C; Abdel-Rasoul, M; Roy, S; LaPerle K; Powell H.(2013). The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healing. Clinical Ophthalmology. Vol. 7 (January): 185-191.
  • Christoforidis, JB; Williams MM; Epitropoulos F; Knopp MV.(2013). The subconjunctival bleb that forms at the injection site after intravitreal injection is drug not vitreous. Clinical & Experimental Ophthalmology Aug;41(6):614-5 .DOI: 10.1111/ceo.12074.
  • Christoforidis, JB; Hinkle, GH; Wang J; Jiang A; Pratt C; Williams, MM; Knopp MV.(2013). Pharmacokinetic properties of intravitreally placed I-124 radiolabeled bevacizumab and ranibizumab after vitrectomy and lensectomy in a rabbit model. Retina 33(5):946-52.
  • Christoforidis, JB; Xie Z; Jiang A; Wang J; Pratt C; Gemensky-Metzler A; Abdel-Rasoul M; Roy S; Liu Z.(2013). Serum levels of intravitreal bevacizumab after vitrectomy, lensectomy and non-surgical controls. Current Eye Research Jul;38(7):761-6.
  • Wang J, Jiang A, Joshi M, Christoforidis JB.(2013). Drug Delivery Implants in thebTreatment of Vitreous Inflammation. Mediators of Inflammation Mediators Inflamm. 2013;2013:780634. doi: 10.1155/2013/780634. Epub 2013 Sep 28
  • Jiang A, Wang J, Joshi M, Christoforidis JB. (2013). Systemic treatments for non-infectious vitreous inflammation. . Mediators of Inflammation 2013:515312. doi: 10.1155/2013/515312. Epub 2013 Nov 20.
  • Agrawal S, Joshi M, Christoforidis JB.(2013). Vitreous inflammation associated with intravitreal anti-VEGF Pharmacotherapy. Mediators of Inflammation 2013:943409. doi: 10.1155/2013/943409. Epub 2013 Nov 6
  • Joshi M, Agrawal S, Christoforidis JB.(2013). Inflammatory Mechanisms of Idiopathic Epiretinal Membrane Formation. Mediators of Inflammation 2013:192582. doi: 10.1155/2013/192582. Epub 2013 Nov 11
  • Romano, MR and Christoforidis, JB.(2014). Intravitreal Inflammation: From Benchside to Bedside. Mediators of Inflammation. doi: 10.1155/2014/286571. Epub 2014 Feb 10 (IF: 3.92)
  • Agarwal DR, Gelman R, Prospero-Ponce C, Stevenson W, Christoforidis JB.(2015). The vitreoretinal interfaces in diabetic retinopathy. J of Ophthalmology Article ID 392983 http://dx.doi.org/10.1155/2015/392983
  • Gelman R, Stevenson W, Prospero-Ponce C, Agarwal DR, Christoforidis JB.(2015). Retinal damage induced by inner limiting membrane removal. J of Ophthalmology Article ID 939748 http://dx.doi.org/10.1155/2015/939748
  • Romano MR, Valldeperas X, and Christoforidis JB.(2015). Vitreomacular Interface: From Anterior to Tangential Traction. J of Ophthalmology
  • Willoughby AS, Ying GS, Toth CA, Maguire MG, Burns RE, Grunwald JE, Daniel E, Jaffe GJ; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group.(2015). Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology. Sep;122(9):1846-1853.e5. doi: 10.1016/j.ophtha.2015.05.042.
  • Wells JA, Glassman AR, Jampol LM et al; Diabetic Retinopathy Clinical Research Network.(2016). Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema. JAMA Ophthalmol. Feb;134(2):127-34. doi: 10.1001/jamaophthalmol.2015.4599.
  • Daniel E, Shaffer J, Ying GS, Grunwald JE, Martin DF, Jaffe GJ, Maguire MG; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group.(2016). Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Ophthalmology. 2016 Mar;123(3):609-16. doi: 10.1016/j.ophtha.2015.10.034.
  • Prospero-Ponce C, Stevenson W, Agarwal DR, Gelman R, Christoforidis JB.(2016). Ocriplasmin: Who is the best patient candidate?. Clin Ophthalmol 10:485-495 Mar 2016. http://dx.doi.org/10.2147/OPTH.S97947
  • Stevenson W, Prospero-Ponce C, Gelman R, Agarwal DR, Christoforidis JB.(2016). Primary Epiretinal Membrane: Optical Coherence. Tomography-Based Classification; Clin Ophthalmol 10:527-534 Mar 2016. http://dx.doi.org/10.2147/OPTH.S97722
  • John B. Christoforidis, Karen Briley, Prayna Bhatia, Lai Wei, Krishan Kumar and Michael V. Knopp.(2017). Systemic biodistribution and intravitreal pharmacokinetic properties of bevacizumab, ranibizumab and aflibercept in a non-human primate model. Invest Ophth Vis Sci. 2017 Vol.58, 5636-5645. doi:10.1167/iovs.17-22431
  • Naghmehossadat E., Christoforidis J., Kuo, P. 18F-FDG PET/CT for Monitoring Response to Therapy of Choroidal Metastasis.(2017). The Journal of Nuclear Medicine Technology 2017 Nov 10. pii: jnmt.117.198341. doi: 10.2967/jnmt.117.198341. The Journal of Nuclear Medicine Technology 2017 Nov 10. pii: jnmt.117.198341. doi: 10.2967/jnmt.117.198341
  • Christoforidis, JB and Chang SC., (2014). Quinine. In Encyclopedia of Toxicology. 3rd ed.. Edited by Philip Wexler. New York, NY, USA: Elsevier. .
  • Romano Mario R MD PhD, Christoforidis John B MD, Vallejo-Garcia Jose L MD., (2013). Exposure and infection of scleral buckle. In Complications of Vitreo-Retinal Surgery.. Edited by Noemi Lois, MD and David SH Wong, MD. New York, NY, USA: Springer. .
  • Werner S, Christoforidis, JB., Diabetic Retinopathy and Obstructive Sleep Apnea, Eye Diseases Associated With Obstructive Sleep Apnea. Edited by Mingwu Wang, MD. Nova Science Publishers pp. 81-93.
  • Pollard K, Christoforidis, JB., Central Serous Chorioretinopathy and Obstructive Sleep Apnea, Eye Diseases Associated With Obstructive Sleep Apnea. Edited by Mingwu Wang, MD. Nova Science Publishers pp. 69-79.
  • Imbornoni L, Christoforidis, JB, Retinal Venular Occlusions and Obstructive Sleep Apnea, Eye Diseases Associated With Obstructive Sleep Apnea. Edited by Mingwu Wang, MD. Nova Science Publishers pp. 55-67.

Greggory Gahn, M.D.

  • Gahn GM, Khanani AM, Gonzalez VH. Full-Thickness Macular Hole (FTMH) and Vitreomacular Traction (VMT): Comparison of Visual Results in Patients Receiving Pars Plana Vitrectomy (PPV) for FTMH in One Eye and Ocriplasmin in the Contralateral Eye. Investigative Ophthalmology & Visual Science. June 2017, Vol.58, 3697.
  • Gahn, G.M., Khanani, A.M. The potential role of Tie2 activators in the treatment of macular edema. Drugs of the Future 2017, 42(11): 693.
  • Khanani AM, Freeman PD, Gahn GM, and Stanko, S, Pipeline for Neovascular AMD Runs Full: An update on small-molecule anti-VEGF agents, anti-angiopoietin-2 antibodies, topical drops and port delivery, Retina Specialist 2017, 39-41.
  • Gahn G, Khanani AM, Gonzalez VH, Markoff JI, Khalef H. Full-Thickness Macular Hole (FTMH) and Vitreomacular Traction (VMT): Comparison of visual results in patients receiving pars plana vitrectomy (PPV) for FTMH in one eye and ocriplasmin in the contralateral eye. Investigative Ophthalmology & Visual Science, June 2017, Vol. 58, 3697.
  • Gahn GM, Khanani AM. New Therapies of Neovascular AMD beyond Anti-VEGF Injections. Vision (Basel). 2018
  • Khanani AM, Cohen GL, Gahn GM. A Randomized, Double-Masked, Prospective Clinical Trial to Evaluate Pain and Inflammation After Intravitreal Injection of Aflibercept or Ranibizumab in Patients with Diabetic Macular Edema: The SOLAR Study. Investigative Ophthalmology & Visual Science. 2018; 59(9):1475
  • Koci M, Gahn GM, Freeman PD, Hill L, Taylor SA, Aziz AM, Khanani AM. Retrospective Evaluation of Neovascular Age-Related Macular Degeneration Managed with Treat-And-Extend Regimen: 5-Year Results of the RENO Study. Investigative Ophthalmology & Visual Science. 2018; 59(9):810.
  • Khanani AM, Gahn GM, Koci MM, Dang JM, Brown SM, Hill LF. Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better. Clinical Ophthalmology, February 13, 2019, Vol. 13, 347-351.
  • Dang J, Khanani AM, Gahn GM. Efficacy of the Treat-and-Extend Regimen in the Management of Neovascular Age-Related Macular Degeneration: 5-year Results of the RENO Study. Investigative Ophthalmology & Visual Science. July 2019, Vol.60, 101.
  • Khanani AM, Gahn GM, Markoff JI, Khalef, H, Gonzalez V, Coney J, Fineman MS, Haller JA. Full-Thickness Macular Hole and Symptomatic Vitreomacular Adhesion: Comparison of Visual Results in Patients Receiving Pars Plana Vitrectomy in One Eye and Ocriplasmin in the Fellow Eye. Journal of Vitreoretinal Diseases, August 21, 2019.
  • Gahn GM, Khanani AM, Khan M, Aziz AA, Siddiqui FA, London NJ, Mukkamala LK, Morse LS. Purtscher's-like retinopathy associated with acute pancreatitis. Am J Ophthalmol Case Rep. 2020 Aug 20;20:100892.
  • Romero C, Vannavong, Dang JM, Aziz AA, Shappell PE, Wadsworth A, Siddiqui F, Koci M, Gahn GM, Mojumber Nazrul, Hagen MM, Yang W, Chhablani J, Khanani AM. Efficacy of the Treat-and-Extend Regimen in the Management of Neovascular Age-Related Macular Degeneration: 7-year Results of the RENO Study. Investigative Ophthalmology & Visual Science 2021; 62(8):436
  • Fong RD, Thomas M, Romero C, Vannavong J, Dang JM, Aziz AA, Shappell P, Wardsworth A, Siddiqui F, Koci M, Gahn GM, Mojumder N, Hagen M, Yang W, Chhablani J, Khanani AM. Efficacy of the Treat-and-Extend Regimen in the Management of Neovascular Age-related Macular Degeneration: 8-year Results of the RENO Study. Investigative Ophthalmology & Visual Science June 2022, Vol.63, 1320 – F0154.
  • Singh SR, Shah SV, Ahmed A, Vannavong J, Sulharia H, Fong R, Romero C, Wadsworth A, Gahn GM, Khanani AM, Chhablani J. A pilot image-based analysis of changes in pigment epithelial detachment composition in neovascular age-related macular degeneration. Indian Journal of Ophthalmology - Case Reports. 2024 Apr 1;4(2):515-8.
  • Penha FM, Masud M, Khanani ZA, Thomas M, Fong RD, Smith K, Chand A, Khan M, Gahn GM, Melo GB, Khanani AM. Review of real-world evidence of dual inhibition of VEGF-A and ANG-2 with faricimab in NAMD and DME. Int J Retin Vitr 10, 5. 2024.
  • Khan H, Aziz AA, Khanani Z, Khan H, Mojumder O, Gahn GM, Khanani AM. Approved treatments for neovascular age-related macular degeneration: current safety and future directions. Expert Opinion on Drug Safety. 2024 Sep;23(9):1109-1114.
  • Khan H, Khan H, Aziz AA, Gahn GM, Barakat MR, Corradetti G, Danzig CJ, Graff JM, Nielsen J, Wolfe J, Sadda SR, Khanani AM. The Real-World Efficacy and Safety of Faricimab in Diabetic Macular Edema: The TAHOE Study. Investigative Ophthalmology & Visual Science. 2024 Jun 17;65(7):6259.
  • Khanani AM, Aziz AA, Khanani ZA, Khan H, Mojumder O, Sulahria H, Khanani I, Khan H, Gahn GM, Mishra K. Subretinal Gene Therapy for Treatment of Retinal and Choroidal Vascular Diseases,American Journal of Ophthalmology,2024 Dec 07,ISSN 0002-9394,
  • Gahn GM, Kaiser PK, Khanani AM, Danzig CJ, Heier JS, Clark J, Zhu L, Patel H, Luo D, Patel N, Jaffe GJ. The 18-Month Efficacy of Avacincaptad Pegol in Geographic Atrophy: Pooled Results from GATHER1 and GATHER2. Investigative Ophthalmology & Visual Science. 2024 Jun 17;65(7):4400.
  • Aziz AA, Khan H, Khanani ZA, Thomas MJ, Khan H, Ahmed A, Gahn GM, Khanani AM. Review of Gene Therapy Clinical Trials for Retinal Diseases. Int Ophthalmol Clin. 2024 Jan 1;64(1):141-151.
  • Khanani I, Aziz AA, Khanani ZA, Khan H, Mojumder O, Sulahria H, Ali H, Khan H, Rahimzadeh TS, Vannavong J, Gahn GM, Khanani AM. The Safety of Recently Approved Therapeutics in Age-Related Macular Degeneration. International Ophthalmology Clinics 65(1):p 3-7, Winter 2025
  • Aziz AA, Khanani AM, Khan H, Lauer E, Khanani I, Mojumder O, Khanani ZA, Khan H, Gahn GM, Graff JT, Abbey AM, Almeida DRP, Barakat MR, Corradetti G, Graff JM, Haug SJ, Nielsen JS, Sheth VS, Sadda SR, Hadas I, Benyamini G, Nahen K, Mohan N. Retinal fluid quantification using a novel deep learning algorithm in patients treated with faricimab in the TRUCKEE study. Eye (Lond). 2025 Apr;39(6):1099-1106.
  • Sulahria H, Mojumder O, Gahn GM, Khanani AM. Bilateral paracentral acute middle maculopathy associated with open mitral valve repair. American Journal of Ophthalmology Case Reports. Volume 38. 2025.
  • Gahn GM, Khan H, Aziz, AA, Khanani AM, Shah CP. Gene Therapy for Neovascular Age-Related Macular Degeneration: What's Ahead? Retina Times. Spring 2025. Volume 43.
  • Khanani AM, Aziz AA, Khanani ZA, Khan H, Mojumder O, Sulahria H, Khanani I, Khan H, Gahn GM, Mishra K. Subretinal Gene Therapy for Treatment of Retinal and Choroidal Vascular Diseases. Am J Ophthalmol. 2025 Sep;277:512-517. doi: 10.1016/j.ajo.2024.12.002. Epub 2024 Dec 7.
  • Sivachandran N, Ji PX, Khan H, Pickel L, Mojumder O, Aziz AA, Khan H, Sulahria H, Gahn GM, Khanani AM. Visual and Anatomic Outcomes of Faricimab in Naïve Neovascular Age-Related Macular Degeneration with Subretinal Hemorrhage: A Multi-Centre Retrospective Analysis. Clin Ophthalmol. 2026
Retired

Reid F. Schindler MD, FRCS(C), FAC(S)

  • Carcinoma of the Lacrimal Sac Canadian Journal of Ophthalmology, 1/1973
  • Choroidal Metastasis From Carcinoma of the Breast Canadian Journal of Ophthalmology, 4/1973
  • Hemangioma of the Optic Disc Canadian Journal of Ophthalmology, 7/1975
  • Intraocular infections Medicine North American, Winter 1980
  • Controlled Trial to Evaluate the Role Of Vitamin E On The Incidence And Severity Of RLF In Low Birth Weight Infants. Lancet 1982; 1: 1087-91
  • Vitamin E And Retrolental Fibroplasia: Improved Visual Outcome With Early Vitamin E Ophthalmology; Volume 90, No 5, May 1983
  • Endophthalmitis, A Complication of Intraocular Foreign Body Presented at Western Retina Study Club Annual Meeting, 1989